It's been a rough start to 2025 for Merck (NYSE: MRK) shareholders following a less-than-stellar fourth-quarter earnings ...
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we ...
Two heads are better than one, as the saying goes, and sometimes two instruments, ingeniously recombined, can accomplish feats that neither could have done on its own.
New R&D headquarters at Science Square to drive innovation and create 110 high-paying Jobs in Atlanta.
Mexican action thriller Counterstrike is headed to Netflix in February 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results